Position in INVA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$11,553,094
+$4,134,588 QoQ
Shares Held
495,841
+33.6% QoQ
Ownership
0.672%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.71119774282482.ToString("F0")%
Shared 0.ToString("F0")%
None 0.28880225717518315.ToString("F0")%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $4,606,751,734 across 214 Biotechnology names. INVA ranks #29 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,231,008 | $951,126,014 | |
| 2 | EXEL |
Exelixis, Inc.
|
13,095,741 | $561,676,326 | |
| 3 | INCY |
Incyte Corp
|
5,807,930 | $546,642,368 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
7,676,541 | $433,647,798 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
913,104 | $302,118,715 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,338,458 | $253,035,481 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,782,038 | $181,424,357 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,946,858 | $164,727,963 |
All Filings in INVA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $11,553,094 | 495,841 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $7,418,506 | 371,111 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $5,520,113 | 302,472 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,952,806 | 196,755 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $3,035,975 | 167,456 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $2,466,110 | 142,139 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $3,023,443 | 156,574 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $2,875,067 | 175,309 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,678,475 | 175,753 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,197,574 | 199,350 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,016,832 | 309,225 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $4,563,017 | 358,446 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,004,012 | 533,690 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,332,740 | 402,471 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,439,009 | 296,211 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,235,092 | 151,429 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,536,204 | 131,070 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,245,398 | 130,168 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,961,770 | 117,401 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,631,581 | 121,669 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,604,024 | 134,228 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $2,349,280 | 189,611 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,864,948 | 178,464 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $3,043,865 | 217,730 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $2,703,812 | 229,916 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||